]>
IRCT2016112615965N8 IRCT 2017-04-20 Rafsanjan University of Medical Sciences The effect of Arnigol cream on pain intensity caused by needles in hemodialysis patients The effects of Arnigol cream on pain associated with arteriovenous fistula puncture among patients receiving hemodialysis 2016-11-26 anticipated 71 Complete https://irct.ir/trial/15074 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Other design features: One puncture site randomly simple(flip the coin) will allocate to the experiment and the other one to the placebo. 2 Chronic renal failure. Intervention 1: For every hemodialysis patient two needles are needed(Arterial needle and venous needle) that insert consecutively, One puncture site was randomly allocated to the experiment and the other one to the placebo.Before needle insertion, the experiment sites will treat for ten minutes with respectively five milliliters of Arnigol cream(the cream is produce of GOLDARU company and its 100 grams contain 5g ARNICA extract). After inserting needles, pain intensity will be measured. Intervention 2: And other needle as control site scrubbing by placebo (vitamin A and D ointment) as the same amount (0.5 cc) 10 minutes before insertion. After inserting needles, pain intensity will be measured.
public
scientific Dr. Majid Kazemi
Rafsanjan University of Medical Sciences, Imam Ali Boulevard, Rafsanjan
Rafsanjan Iran (Islamic Republic of) 7717932777 +98 34 3425 5900 dr.kazemi.n@rums.ac.ir Rafsanjan University of Medical Sciences Iran (Islamic Republic of) Inclusion criteria: Patients were included if they were receiving hemodialysis through arteriovenous fistula at least two times a week for three consecutive months, were fully conscious, aged eighteen or more, did not suffer from neuropathies or peripheral vascular problems, had no sign of inflammation at fistula site, received no topical analgesic at fistula site prior to the study intervention, and had no known allergy to Arnigol cream. Exclusion criteria: Unsuccessful puncture at the first attempt and participants’ voluntary withdrawal from the study 18 years 85 years Both N18.5 Chronic kidney disease, stage 5 Treatment - Drugs Treatment - Drugs For every hemodialysis patient two needles are needed(Arterial needle and venous needle) that insert consecutively, One puncture site was randomly allocated to the experiment and the other one to the placebo.Before needle insertion, the experiment sites will treat for ten minutes with respectively five milliliters of Arnigol cream(the cream is produce of GOLDARU company and its 100 grams contain 5g ARNICA extract). After inserting needles, pain intensity will be measured. And other needle as control site scrubbing by placebo (vitamin A and D ointment) as the same amount (0.5 cc) 10 minutes before insertion. After inserting needles, pain intensity will be measured. Pain. Timepoint: Immediately after entering needles. Method of measurement: Based on a numerical scale VAS. Rafsanjan University of Medical Sciences Approved 2016-01-09 Ethics committee of Rafsanjan University of Medical Sciences Rafsanjan University of Medical Sciences, Imam Ali Boulevard, Rafsanjan Rafsanjan Iran (Islamic Republic of)